Interactive Investor
>>

Dimerix Ltd (ASX:DXB) Share Price

DXB

Dimerix Ltd

APAC company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XASX

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+11, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.Dimerix Ltd is a clinical stage biotechnology company. The company is focused on developing new therapeutics discovered using its proprietary drug development platform, Receptor-Heteromer Identification Technology (HIT).

ASX:DXB

AU000000DXB7

AUD

Loading...

Loading Comparison

Latest DXB News